Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (441)	6/30/1998 1:01:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 1722

Johnson & Johnson (JNJ) fell as much as 2 to 75 as the drug and medical-supplies company's Propulsid drug, used to treat nighttime heartburn, and sold by its Janssen Pharmaceutica unit, may cause heart problems in certain patients, the U.S. Food and Drug Administration said. The FDA said the drug's packaging will include a new label that will tell doctors to try other drugs first before turning to Propulsid. Source: Bloomberg June 30, 1998